very intrigued by this company. looks to be class act with approved exclusive product with broad applications for cancer. why can't this become a standard of care for all related cancer surgeries-particularly given acceptance by so many renowned entities via abstracts etc. all this and a market cap under $20 million. no reason this shouldn't be in dollars pps-wise. bought some for first time last 2 weeks. the best